in this issue
Markets :: Specialty Chemicals :: Food additives
Lonza Licenses Biotech to Roche
10:22 AM MDT | July 30, 2007 | Chemical Week Editorial Staff
Lonza says it has agreed to license its glutamine synthetase (GS) expression system and GS-CHO protein free system to Roche for the manufacture of therapeutic recombinant proteins and monoclonal antibodies. Financial terms were not disclosed. The agreement builds on a supply agreement between Lonza and Roche for undisclosed...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee